437 related articles for article (PubMed ID: 12656664)
1. The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients.
Socin HV; Chanson P; Delemer B; Tabarin A; Rohmer V; Mockel J; Stevenaert A; Beckers A
Eur J Endocrinol; 2003 Apr; 148(4):433-42. PubMed ID: 12656664
[TBL] [Abstract][Full Text] [Related]
2. Long-term preoperative management of thyrotropin-secreting pituitary adenoma with octreotide.
Iglesias P; Díez JJ
J Endocrinol Invest; 1998 Dec; 21(11):775-8. PubMed ID: 9972679
[TBL] [Abstract][Full Text] [Related]
3. Primary Medical Treatment of Thyrotropin-Secreting Pituitary Adenomas by First-Generation Somatostatin Analogs: A Case Study of Seven Patients.
Rimareix F; Grunenwald S; Vezzosi D; Rivière LD; Bennet A; Caron P
Thyroid; 2015 Aug; 25(8):877-82. PubMed ID: 26244412
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and treatment of pituitary adenomas.
Chanson P; Salenave S
Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and treatment of TSH-secreting adenomas: review of a longtime experience in a reference center.
Nazato DM; Abucham J
J Endocrinol Invest; 2018 Apr; 41(4):447-454. PubMed ID: 29022276
[TBL] [Abstract][Full Text] [Related]
7. Thyrotropin-secreting pituitary adenomas: clinical and biochemical heterogeneity. Case reports and follow-up of nine patients.
Gesundheit N; Petrick PA; Nissim M; Dahlberg PA; Doppman JL; Emerson CH; Braverman LE; Oldfield EH; Weintraub BD
Ann Intern Med; 1989 Nov; 111(10):827-35. PubMed ID: 2479309
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas.
Caron P; Arlot S; Bauters C; Chanson P; Kuhn JM; Pugeat M; Marechaud R; Teutsch C; Vidal E; Sassano P
J Clin Endocrinol Metab; 2001 Jun; 86(6):2849-53. PubMed ID: 11397898
[TBL] [Abstract][Full Text] [Related]
9. Surgical Outcome and Treatment of Thyrotropin-Secreting Pituitary Tumors in a Tertiary Referral Center.
Herguido NG; Fuentes ED; Venegas-Moreno E; Maorad LB; Flores-Martinez A; Ruiz PR; Dueñas MC; Roldán F; Fajardo E; Ruiz-Valdepeñas EC; Kaen A; Martín Schrader I; Cano DA; Soto-Moreno A
World Neurosurg; 2019 Oct; 130():e634-e639. PubMed ID: 31276853
[TBL] [Abstract][Full Text] [Related]
10. [Thyrotropin-secreting pituitary adenomas].
Caron P
Presse Med; 2009 Jan; 38(1):107-11. PubMed ID: 18980829
[TBL] [Abstract][Full Text] [Related]
11. Hyperthyroidism caused by an ectopic thyrotropin-secreting tumor of the nasopharynx: a case report and review of the literature.
Tong A; Xia W; Qi F; Jin Z; Yang D; Zhang Z; Li F; Xing X; Lian X
Thyroid; 2013 Sep; 23(9):1172-7. PubMed ID: 23402621
[TBL] [Abstract][Full Text] [Related]
12. TSH-secreting pituitary adenomas: follow-up of 11 cases and review of the literature.
Ness-Abramof R; Ishay A; Harel G; Sylvetzky N; Baron E; Greenman Y; Shimon I
Pituitary; 2007; 10(3):307-10. PubMed ID: 17347873
[TBL] [Abstract][Full Text] [Related]
13. Treatment of thyrotropin-secreting pituitary adenomas with octreotide.
Shimatsu A; Murabe H; Kamoi K; Suzuki Y; Nakao K
Endocr J; 1999 Feb; 46(1):113-23. PubMed ID: 10426575
[TBL] [Abstract][Full Text] [Related]
14. Clinical aspects and therapeutic outcome in thyrotropin-secreting pituitary adenomas: a single center experience.
Macchia E; Gasperi M; Lombardi M; Morselli L; Pinchera A; Acerbi G; Rossi G; Martino E
J Endocrinol Invest; 2009 Oct; 32(9):773-9. PubMed ID: 19636221
[TBL] [Abstract][Full Text] [Related]
15. Thyrotropin-secreting pituitary adenomas. Clinical and biological heterogeneity and current treatment.
Sanno N; Teramoto A; Osamura RY
J Neurooncol; 2001 Sep; 54(2):179-86. PubMed ID: 11761434
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis, pathology, and management of TSH-secreting pituitary tumors. A single-center retrospective study of 20 patients from 1981 to 2014.
Căpraru OM; Gaillard C; Vasiljevic A; Lasolle H; Borson-Chazot F; Raverot V; Jouanneau E; Trouillas J; Raverot G
Ann Endocrinol (Paris); 2019 Sep; 80(4):216-224. PubMed ID: 31400861
[TBL] [Abstract][Full Text] [Related]
17. [111In-DTPA-D-Phe]-octreotide scintigraphy in functioning and non-functioning pituitary adenomas.
Boni G; Ferdeghini M; Bellina CR; Matteucci F; Castro Lopez E; Parenti G; Canapicchi R; Bianchi R
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):90-3. PubMed ID: 9002759
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics of patients with thyrotropin-secreting pituitary adenoma.
Wu YY; Chang HY; Lin JD; Chen KW; Huang YY; Jung SM
J Formos Med Assoc; 2003 Mar; 102(3):164-71. PubMed ID: 12783133
[TBL] [Abstract][Full Text] [Related]
19. Thyrotropin-secreting pituitary adenomas: biological and molecular features, diagnosis and therapy.
Losa M; Fortunato M; Molteni L; Peretti E; Mortini P
Minerva Endocrinol; 2008 Dec; 33(4):329-40. PubMed ID: 18923369
[TBL] [Abstract][Full Text] [Related]
20. Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment.
Teramoto A; Sanno N; Tahara S; Osamura YR
Acta Neuropathol; 2004 Aug; 108(2):147-53. PubMed ID: 15185102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]